查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1133522

移动健康 (mHealth) 全球市场-2022-2029

Global Mobile health (mHealth) Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

全球移动医疗市场的推动力在于医疗保健意识的提高、智能手机和平板电脑终端因其便利性而得到越来越多的使用，以及对个性化医疗的日益关注。

移动医疗 (mHealth) 带来的好处和便利正在推动市场增长。

移动健康带来的好处和便利正在推动全球市场的增长。例如，移动健康技术使患者能够 24/7 全天候连接以快速发送安全消息、预约和接收远程医疗。特别是，远程医疗是患者在移动设备上使用 mHealth 应用程序增长最快的方式。它还可以通过提供使患者更有可能适当服药的功能来提高服药依从性，例如自动用药和补充提醒以及教育信息。此外，远程医疗允许患者使用移动设备和移动医疗技术来收集、输入或自动收集健康数据并将其传达给他们的医疗保健提供者，而远程医疗是家庭护理的一个子类别，远程患者护理可以实现监控。此外，M Health 提高了药物调整的准确性，从而提高了患者的安全性。例如，Cureatr Meds 360 解决方案可让医疗保健专业人员和其他临床医生在 iPhone 和 Android 屏幕上清楚地了解患者的所有处方药的可用性、补充历史、剂量变化等。

隐私和安全风险限制了全球移动医疗 (mHealth) 的发展。

但是，随着黑客攻击和数据差异的持续威胁，安全和隐私问题将在预测期内阻碍全球市场的增长。

COVID-19 影响分析

在疫情爆发期间，远程医疗和虚拟护理受到了广泛关注，在总有感染病毒风险的情况下，抗击疫情变得更加方便，这对全球经济增长产生了重大影响市场。例如，Harward 全球健康研究所创建了一个 COVID-19 预测模型，以启用针对 COVID-19 患者、住院、ICU 入院、呼吸机使用和死亡的早期预警系统，使医护人员能够主动采取行动以阻止流行病。即使在 COVID-19 的威胁已经过去之后，虚拟医疗保健策略也能带来高利润并且得到很好的实施。

全球移动健康 (mHealth) 报告将提供对大约 40 多个市场数据表、45 多个图表和 200 页（大约）的访问。

内容

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因子
    • 驱动程序
      • 提供好处和便利
      • 提高认识
    • 阻碍因素
      • 隐私和安全风险
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按服务分类

  • 健身与保健解决方案
  • 咨询服务
  • 监控
  • 诊断服务
  • 治疗
  • 预防

第 8 章. 按应用程序

  • 体温监测器
  • 血糖监测仪
  • 心臟监护仪
  • 血流动力学监测仪
  • 神经系统监视器
  • 远程病人监护设备
  • 呼吸监护仪

第 9 章，最终用户

  • 医疗保健提供者
  • 医疗保健消费者
  • 公共和私人保险公司
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准

第 12 章公司简介

  • GE healthcare
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • One Medical
  • Apple
  • OMADA Health
  • Omron Healthcare
  • LifeWatch
  • Medtronics Plc
  • Johnson & Johnson
  • Samsung Healthcare Solutions
  • AT&T
  • Philips Healthcare
  • Bayer Healthcare

第13章 DataM

简介目录
Product Code: DMHCIT234

Market Overview

Mobile Health Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY% during the forecast period (2022-2029).

Mobile health (mHealth) is a broad phrase for using mobile phones and other wireless technology in medical care. The most common application of mHealth is the use of mobile devices to educate consumers about preventive healthcare services.

Market Dynamics

Growing awareness about healthcare management, increasing use of smartphones and tablets owing to the benefits and convenience, and increasing focus on personalized medicine drive the global mHealth market.

The benefits and convenience offered by mobile health (mHealth) are pushing the market growth.

The benefits and convenience offered by mobile health are fueling the global market growth. For instance, mobile health technologies help patients quickly send secure messages, schedule appointments and connect 24/7 for telemedicine visits. In particular, telemedicine is among the fastest growing ways patients use mHealth apps on their mobile devices. It also improves medication adherence by providing patients with features such as automated medication and refills reminders and educational information that enhances the probability, they'll take their medications properly. Furthermore, telehealth enables patients to use mobile devices and mobile health technology to gather, enter, or automatically collect health data and convey it to healthcare providers, allowing remote patient monitoring, a subcategory of home care. Moreover, Mhealth improves medication reconciliation precision, that in turn improves patient safety example of which is the Cureatr Meds 360 solution offers providers and other clinicians a bird's-eye view of all medications a patient has been prescribed with pick up and refill history, dosage changes, and more on an uncluttered, iPhone or Android screen display.

Privacy and security risks will restrain global mobile health (mHealth) growth.

However, with the threat of constant hacking or data discrepancy, security and privacy concerns will hamper the global market growth in the forecast period.

COVID-19 Impact Analysis

During the outburst, there was an increased focus on telemedicine and virtual care, which made it a bit convenient to fight against the pandemic with the constant risk of getting infected with the virus, significantly impacting the global market growth. For example, Harward Global Health Institute created a COVID-19 forecasting model enabling an early alert system for COVID-19 cases, hospitalizations, ICU admissions, ventilator utilization, and deaths, allowing healthcare professionals to act with a proactive attitude in squelching the pandemic. Even after the threat of COVID-19 virtual healthcare strategy is highly practiced since it offers considerable benefits.

Segment Analysis

The monitoring services segment of mobile health (mHealth) is expected to grow at the fastest CAGR during the forecast period (2022-2029).

The monitoring services are expected to dominate the global market during the forecast period (2022-2029). Owing to the advantages and benefits offered by remote monitoring using smartphones since there are over three billion smartphone users worldwide, making it the most straightforward manner to reaching out to multitudes and remote areas, with smartphone technologies, wearable sensors, and smartphone platforms, remote monitoring the health/vitals of patients have become very easy and convenient. Resulting in preventive care, well-timed diagnosis, screening of ailments, and timely treatment, which in turn has reduced and will significantly reduce the number of hospital visits, and hospitalization, reducing hospital-induced infections. Collectively, all these benefits result in improving the quality of life. Furthermore, for effective patient care and safety, constant monitoring of physiological parameters is needed, which the technology's flexibility allows through real-time basis monitoring of the parameters in non-clinical environments such as home, office, park, traveling, Etc. and ease the communication of alerts/notifications to the healthcare professional, so urgent attention can be provided remotely in case of an emergency.

Geographical Analysis

The North America region will dominate the global mobile health (mHealth).

North America is expected to dominate the global market during the forecast period (2022-2029) since most of the key players in this market, such as one medical, GE Healthcare, Apple, OMADA Health, Medtronics Plc, Johnson & Johnson, AT&T are U.S. based and with different market, strategies have a hold over a large share of the market. For instance, in February 2022, Hartford HealthCare and One Medical Announce Collaboration Focused on Seamless Coordinated Care; in September 2021, One Medical acquired Iora Health, a human-centered, value-based primary care organization with built-for-purpose technology focused on serving the Medicare senior population.

Also, in April 2021, Omada Health Launched the First Virtual Cardiometabolic Clinic, a Physician-Guided Care Program; in May 2020, Omada Health Acquired Physera, a leading musculoskeletal care company that delivers interventions digitally and via telehealth.

Competitive Landscape

The key players operating in the global mobile health (mHealth) market are One Medical, GE Healthcare, Apple, OMADA Health, Omron Healthcare, LifeWatch, Medtronics Plc, Johnson & Johnson, Samsung Healthcare Solutions, AT&T, Philips Healthcare, and Bayer Healthcare. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of Mobile health (mHealth) globally. For instance, In January 2022, OMRON Healthcare, Inc. introduced VitalSight in the United States, Hypertension Plus in the U.K., and HeartVoice in Singapore to encourage more powerful active health condition management, boost the patient-physician association, and guide behavior change that reduces or eliminates heart attack and stroke risk.

GE Healthcare

Overview:

GE Healthcare is headquartered in Chicago, Illinois, United States, founded in 2004. It is a subsidiary of American Multinational Conglomerate General Electric. It is a leading manufacturer and distributor of diagnostic imaging and radiopharmaceuticals for imaging modalities used in medical imaging procedures.

Product Portfolio:

GE Healthcare's product portfolio for mHealth has Carestation Insights LIVE Mobile Application, Centricity Universal Viewer Zero Footprint, Vscan Extend Bladder Volume App, Vscan Extend Lung Protocol App, Vscan Extend Protocol Creator App, Etc.

The global mobile health (mHealth) report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Benefits and Convenience Offered
      • 4.1.1.2. Increased Awareness
    • 4.1.2. Restraints
      • 4.1.2.1. Privacy and Security Risks
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Service

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Segment
    • 7.1.2. Market Attractiveness Index, By Service Segment
  • 7.2. Fitness & Wellness Solutions
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Consultation Services
  • 7.4. Monitoring
  • 7.5. Diagnostic
  • 7.6. Treatment
  • 7.7. Prevention

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Body and Temperature Monitors
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Blood Glucose Monitors
  • 8.4. Cardiac Monitors
  • 8.5. Hemodynamic Monitors
  • 8.6. Neurological Monitors
  • 8.7. Remote Patient Monitoring Devices
  • 8.8. Respiratory Monitors

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 9.1.2. Market Attractiveness Index, By End-User Segment
  • 9.2. Healthcare Providers
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Healthcare Consumers
  • 9.4. Public & Private Insurers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. GE Healthcare
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. One Medical
  • 12.3. Apple
  • 12.4. OMADA Health
  • 12.5. Omron Healthcare
  • 12.6. LifeWatch
  • 12.7. Medtronics Plc
  • 12.8. Johnson & Johnson
  • 12.9. Samsung Healthcare Solutions
  • 12.10. AT&T
  • 12.11. Philips Healthcare
  • 12.12. Bayer Healthcare

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us